ライフサイエンスコーパス: sirtuin 1

1 of the NAD(+)-dependent protein deacetylase sirtuin 1.

2 effects of resveratrol were mediated through Sirtuin 1.

3 tylated by the stress-responsive deacetylase Sirtuin 1.

4 ignaling and drives senescence by inhibiting sirtuin-1.

5 nescence by restoring the antiaging molecule sirtuin-1.

6 low AGE diets with increased adiponectin and sirtuin-1.

7 udopeptides that were screened against human sirtuins 1-3 to reveal their in vitro inhibition activit

8 signaling, plays a pivotal role in reducing sirtuin-1/6, and its inhibition with an antagomir result

9 mes (HDAC1-11) and NAD(+)-dependent enzymes (sirtuins 1-7).

10 activity of the NAD(+) dependent deacetylase sirtuin 1, a ChREBP-negative target, were down-regulated

11 ox regulation controls enzymatic activity of sirtuin 1, a mechanism we found to be conserved between

12 w that the mammalian SIR2 orthologue, Sirt1 (sirtuin 1), activates a critical component of calorie re

13 protective effects have been associated with sirtuin 1 activation by resveratrol, the mechanisms by w

14 ogenesis, by consuming NAD(+) and decreasing Sirtuin 1 activation of the peroxisome proliferator-acti

15 ty-promoting effects of caloric restriction, Sirtuin 1 activation, inhibition of insulin/insulin grow

16 ylation via maintenance of NAD(+) levels and sirtuin 1 activation.

17 ic ischemia-reperfusion and posttreated with sirtuin 1 activator, SRT1720 (20 mg/kg), or vehicle.

18 to determine the effects of a small molecule sirtuin 1 activator, SRT2104, on inflammation and coagul

19 Indeed, when sirtuin 1 activity was rescued by resveratrol pretreatme

20 of KAL were associated with upregulation of Sirtuin 1 activity within the aortas of both KS-Tg mice

21 t of diabetic pod-HIV mice with the specific Sirtuin-1 agonist BF175 significantly attenuated albumin

22 abetic patients living with HIV and suggests Sirtuin-1 agonists as a potential therapy.

23 Sirtuin 1 also appears to influence lineage/cell-fate de

24 Sirtuin-1 also inhibits cancer metastasis via increasing

25 id hemorrhage injury primarily by increasing sirtuin 1 and inhibiting the Toll-like receptor 4 signal

26 Id1 deficiency also increased expression of Sirtuin 1 and peroxisome proliferator-activated receptor

27 f stored maternal mRNA transcripts including sirtuin 1 and ubiquitin protein ligase E3a, two genes wi

28 t kidney is characterized by upregulation of sirtuin-1 and adenosine monophosphate-activated protein

29 egulation of nutrient deprivation signaling (sirtuin-1 and adenosine monophosphate-activated protein

30 miR-570 is also involved in reduction of sirtuin-1 and cellular senescence and is activated by p3

31 In summary, activation of hepatic AMPK/sirtuin-1 and FGF21/beta-klotho signaling pathways combi

32 3 expression and prevented downregulation of Sirtuin-1 and Foxo3alpha expression in IRPTCs by high gl

33 In vitro, hnRNP F overexpression stimulated Sirtuin-1 and Foxo3alpha with downregulation of acetylat

34 Loss of key antiaging molecules sirtuin-1 and sirtuin-6 may be important in acceleration

35 ithelial cells, using an antagomir, restores sirtuin-1 and suppresses markers of cellular senescence

36 AP, above 0.001%, enhanced the expression of sirtuin-1 and thermogenic uncoupling protein 1 (UCP-1) i

37 We observed that both sirtuins 1 and 7 (SIRT1 and SIRT7) are able to deacetyla

38 nd energy deprivation sensing through SIRT1 (sirtuin-1) and AMPK (adenosine monophosphate-activated p

39 esis and ketogenesis is activation of SIRT1 (sirtuin-1) and its downstream mediators: PGC-1alpha (pro

40 roblast growth factor 21 (FGF21), targets of sirtuin-1, and beta-klotho, which can acts as a tumor su

41 C apoptosis and lower expression of hnRNP F, SIRTUIN-1, and FOXO3alpha than nondiabetic kidneys.

42 rn blot analysis revealed that caspase-2 and sirtuin 1 are the direct targets of miR-34a.

43 ors, AMP-activated protein kinase (AMPK) and sirtuin-1 are activated.

44 residue in the conserved catalytic region of sirtuin 1 as target for glutaredoxin 2-specific deglutat

45 Thus, our study highlights the reduction in Sirtuin-1 as a major basis of CKD progression in diabeti

46 Pharmacologic stimulation of sirtuin 1 attenuates liver injury after hepatic ischemia

47 on of the anti-inflammatory genes Socs1-3 or sirtuin-1 but reduced levels of IL-1beta + IFN-gamma-ind

48 responses consistent with the activation of sirtuin 1 by a small molecule.

49 Here we show that sirtuin 1 deacetylase (Sirt1) deacetylates Nav1.5 at lys

50 Sirtuin 1 deacetylase (SIRT1) regulates cell ageing and

51 levels by the p300 acetyltransferase and the sirtuin 1 deacetylase controls transcriptional activity,

52 ctivity through a mechanism regulated by the sirtuin 1 deacetylase.

53 resses its transcriptional activity, whereas sirtuin 1 deacetylates and activates PGC-1alpha.

54 rom GM3 to GM2 by upregulating B4GALNT1 in a Sirtuin 1-dependent manner.

55 742, but not VEGF-A, was PPARbeta/delta- and sirtuin-1-dependent.

56 bined ethanol and LPS-mediated inhibition of sirtuin 1 expression and activity in macrophages.

57 tly inhibited the TLR4 activation, increased sirtuin 1 expression, and inhibited the subsequent infla

58 d ADH activity through its direct control of sirtuin 1 expression.

59 ve stress and nephropathy via stimulation of Sirtuin-1 expression and signaling in diabetes.

60 Furthermore, sirtuin-1 expression was determined to provide mechanist

61 Sirtuin-1 expression was not influenced by diet in eithe

62 ignalling pathways, along with a decrease in sirtuin-1 expression, a decreased ratio of beta-amyloid

63 ut this response is not explained by altered sirtuin-1 expression.

64 as to determine whether differences exist in sirtuin-1 expression/activity in old vs. young liver gra

65 Instead, triiodothyronine increased sirtuin-1, fibrillin-1, proliferator-activated receptor-

66 Sirtuin-1, Foxo3alpha, and catalase expression were sign

67 lism-by dissociating the PPARgamma inhibitor sirtuin 1 from cell cycle and apoptosis protein 2 (CCAR2

68 Furthermore, we identified that aging alters Sirtuin-1-hepatic nuclear factor 4alpha circuit in hepat

69 in mice, and calorie restriction upregulates sirtuin 1 in humans.

70 Molecular analyses identified the role of sirtuin 1 in preventing cell senescence; shed light on t

71 llular senescence markers, including p21 and sirtuin-1, in both lung epithelial and endothelial cells

72 Sirtuin 1 influences gene expression and other cellular

73 Recent work indicates that sirtuin 1 influences growth-factor responses and mainten

74 AMPK/sirtuin-1 inhibit the activity of STAT3 (signal transduc

75 Moreover, miR-217-mediated sirtuin 1 inhibition was accompanied by increased activi

76 g strategy by preselecting 434 compounds for Sirtuin-1 inhibition from a library of 2.6 million compo

77 Importantly, treating AAV-NT mice with a sirtuin-1 inhibitor markedly reversed many of the observ

78 Sirtuin 1 is an energy-sensing enzyme involved in regula

79 Sirtuin 1 is an energy-sensing enzyme known to modulate

80 ypothesized that pharmacologic activation of sirtuin 1 is protective after hepatic ischemia-reperfusi

81 Sirtuin 1 is required for calorie restriction-induced li

82 We consider recent information on sirtuin 1, its role in aging and metabolism in several s

83 in injury after SAH, primarily by increasing sirtuin 1 levels and inhibiting the TLR4 signaling pathw

84 ur findings provide the first evidence for a sirtuin 1-mediated homeostatic response aimed at maintai

85 NAMPT inhibits CXCR4 through a NAD/Sirtuin 1-mediated inactivation of HIF1alpha-driven CXCR

86 CAF-mediated acetylation and the deacetylase sirtuin-1-mediated deacetylation coexist to maintain CRE

87 The inhibitory action on Sirtuin 1 of approximately half of the proposed compound

88 histone deacetylase 2 enrichment, but not of sirtuin 1 or sirtuin 2, onto GluA1 and GluA2 gene sequen

89 ompared to a competitive benchmark study for Sirtuin-1, our method shows a 12-fold higher hit rate.

90 ochondrial metabolism reorganization through sirtuin 1/peroxisome proliferator-activated receptor gam

91 rations and the AMP-activated protein kinase/sirtuin 1/peroxisome proliferator-activated receptor-gam

92 cade involving AMP-activated protein kinase, sirtuin 1, PGC-1alpha, sirtuin 3, estrogen-related recep

93 heat shock proteins, antioxidant enzymes and sirtuin-1/PGC-1 signalling) are central to the protectiv

94 erestingly, silencing the NAD+-sensor enzyme sirtuin 1 prevented eNAD+-dependent transcriptional repr

95 iption via hnRNP F-responsive element in the Sirtuin-1 promoter.

96 ng Nnmt expression or MNAM levels stabilizes sirtuin 1 protein, an effect that is required for their

97 -570-3p rejuvenates cells via restoration of sirtuin-1, reducing many of the abnormalities associated

98 tudies using inhibitors of PPARbeta/delta or sirtuin-1 showed that the tubulogenic effect of GW0742,

99 ervals, increasing NAD-dependent deacetylase sirtuin-1 signaling important for glucose and lipid meta

100 These results suggest KAL-Sirtuin 1 signalling limits aortic wall remodelling and

101 Sirtuin 1 (SIRT) mRNA levels were lower in PLAC when com

102 We and others previously demonstrated that sirtuin 1 (SIRT-1) regulates apoptosis and cartilage-spe

103 PKalpha) to total AMPKalpha ratio, decreased sirtuin-1 (Sirt-1) and peroxisomal proliferator-activate

104 han the NAD(+)-dependent histone deacetylase Sirtuin-1 (Sirt-1) are unknown.

105 We aimed to explore the value of serum sirtuin-1 (Sirt-1) in the diagnosis of MASLD.

106 Sirtuin-1 (Sirt-1) plays a crucial role in various biolo

107 y decreased levels of the histone deactylase Sirtuin-1 (SirT-1) which has been previously shown to fu

108 that reductions in the cellular deacetylase, sirtuin-1 (SIRT-1), contribute to vascular endothelial d

109 FD-induced mitochondrial dysfunction via the sirtuin-1 (SIRT-1)/ peroxisome proliferator-activated re

110 Here we show that selective knockdown of Sirtuin 1 Sirt1 in hypothalamic Agouti-related peptide-e

111 We show that UnAG rescues sirtuin 1 (SIRT1) activity and superoxide dismutase-2 (S

112 The G6PT-deficient liver displayed impaired sirtuin 1 (SIRT1) and AMP-activated protein kinase (AMPK

113 Sirtuin 1 (SIRT1) and its activator resveratrol are emer

114 on and cartilage mineralization by targeting Sirtuin 1 (SIRT1) and lymphoid enhancer binding factor 1

115 Furthermore, expression of sirtuin 1 (SIRT1) and nicotinamide phosphoribosyl transf

116 Sirtuin 1 (SIRT1) and suppressor of variegation 3-9 homo

117 ted genes are the anti-lipogenic deacetylase sirtuin 1 (Sirt1) and the anti-lipogenic transcription f

118 factor 1 (HES1) and the protein deacetylase sirtuin 1 (SIRT1) at the Isl1 gene.

119 Sirtuin 1 (SIRT1) binds, deacetylates, and thereby inact

120 Whereas sirtuin 1 (SIRT1) can act as a tumor suppressor in some

121 on with sepsis, we report that energy sensor sirtuin 1 (SIRT1) coordinates the epigenetic and bioener

122 und that higher abundance of the deacetylase sirtuin 1 (SIRT1) correlated with lower acetylation occu

123 mice with diabetic neuropathy had decreased sirtuin 1 (SIRT1) deacetylase activity in foot skin, lea

124 mide adenine dinucleotide (NAD(+))-dependent sirtuin 1 (SIRT1) deacetylase plays an important role in

125 Heterologous sirtuin 1 (SIRT1) decreased acetylation of Nrf2 as well

126 Sirtuin 1 (SIRT1) depletion in vascular endothelial cell

127 lele showed lower leptin (LEP)(P = 0.03) and sirtuin 1 (SIRT1) expression (P = 0.04).

128 ctivated protein kinase phosphorylation, and sirtuin 1 (SIRT1) expression.

129 eptor nuclear translocator-like (Arntl), and sirtuin 1 (Sirt1) expression.

130 strate that the NAD(+)-dependent deacetylase sirtuin 1 (Sirt1) functionally and physically interacts

131 e highlighted association of the deacetylase sirtuin 1 (SIRT1) gene with anxiety, its exact role in t

132 The protein encoded by the sirtuin 1 (Sirt1) gene, which is a mouse homolog of yeas

133 rmacological activation that the deacetylase Sirtuin 1 (SIRT1) has an anti-inflammatory role in a les

134 Decreased expression of sirtuin 1 (SirT1) has been implicated in Alzheimer's dis

135 of proteins that co-immunoprecipitated with sirtuin 1 (SIRT1) identified TUB-like protein 3 (TULP3),

136 se of this study was to evaluate the role of sirtuin 1 (SirT1) in exercise- and resveratrol (RSV)-ind

137 of the NAD(+)-dependent lysine deacetylase, sirtuin 1 (SIRT1) in fibrogenesis in the cell culture, a

138 omain (p66Shc) and reduced the expression of sirtuin 1 (Sirt1) in mice and humans.

139 We sought to determine the role of sirtuin 1 (SIRT1) in skin barrier function, FLG expressi

140 dinucleotide (NAD(+))-dependent deacetylase sirtuin 1 (SIRT1) in various tissues.

141 on receptor 1 (AGER1) and of survival factor sirtuin 1 (SIRT1) in white adipose tissue (WAT), skeleta

142 Because Sirtuin 1 (SirT1) induces hepatic gluconeogenesis during

143 Sirtuin 1 (Sirt1) is a class III histone deacetylase tha

144 Sirtuin 1 (SIRT1) is a class III histone deacetylase tha

145 Sirtuin 1 (SIRT1) is a complex NAD(+) -dependent protein

146 The enzyme sirtuin 1 (SIRT1) is a critical regulator of many cellul

147 Sirtuin 1 (SIRT1) is a key physiological regulator of me

148 Sirtuin 1 (Sirt1) is a NAD(+)-dependent deacetylase capa

149 Sirtuin 1 (Sirt1) is a NAD+-dependent deacetylase that e

150 Sirtuin 1 (SIRT1) is a NAD-dependent deacetylase that is

151 Sirtuin 1 (SIRT1) is a nicotinamide adenine dinucleotide

152 Sirtuin 1 (SIRT1) is a nuclear deacetylase that modulate

153 The type III histone deacetylase sirtuin 1 (Sirt1) is a suppressor of both innate and ado

154 udies, we found that the histone deacetylase sirtuin 1 (SIRT1) is a transcriptional modulator of the

155 Sirtuin 1 (SirT1) is an essential nutrient-sensing histo

156 The class III NAD-sirtuin 1 (SIRT1) is an important negative regulator of

157 Sirtuin 1 (SIRT1) is an NAD(+)-dependent deacetylase tha

158 The NAD(+)-dependent deacetylase Sirtuin 1 (SIRT1) is down-regulated in triple-negative b

159 Sirtuin 1 (SIRT1) is involved in both aging and circadia

160 ependent (NAD-dependent) protein deacetylase sirtuin 1 (SIRT1) is involved in the pathophysiology of

161 ximately 7.5 muM) restored the normal TF and sirtuin 1 (SIRT1) levels in MCECs before PGE2 (EC50 appr

162 Sirtuin 1 (SIRT1) NAD(+)-dependent deacetylase regulates

163 AMP-activated protein kinase (AMPKalpha) and sirtuin 1 (SIRT1) pathways in the liver, regardless of m

164 Ethanol-mediated inhibition of hepatic sirtuin 1 (SIRT1) plays a crucial role in the pathogenes

165 Sirtuin 1 (SIRT1) plays an important role in preserving

166 region of Brdt protein appeared to separate sirtuin 1 (Sirt1) protein from contact with the chromoce

167 The NAD(+)-dependent deacetylase Sirtuin 1 (SIRT1) regulates cell metabolism, proliferati

168 We have previously demonstrated that sirtuin 1 (SIRT1) regulates genes involved in gluconeoge

169 Sirtuin 1 (SIRT1) regulates liver regeneration and bile

170 Here, we propose that the nutrient sensor sirtuin 1 (Sirt1) regulates the production of CRH post-t

171 that the stress-responsive genetic regulator sirtuin 1 (Sirt1) selectively augments HIF-2 signaling d

172 iency, along with significant suppression of sirtuin 1 (SIRT1) signaling pathway in the liver.

173 ulation and Th2 inflammation and blockers of sirtuin 1 (Sirt1) to define its roles in these responses

174 d the target of DLA, the binding affinity of Sirtuin 1 (SIRT1) to DLA and DLA derivatives with replac

175 Zymosan produced the location of sirtuin 1 (SIRT1) to the nucleus, enhanced its associati

176 In animal studies, sirtuin 1 (SIRT1) was associated with protection against

177 bservational study, baseline serum levels of sirtuin 1 (SIRT1) were assessed in 147 diabetic patients

178 nt protein kinase II alpha (CaMKIIalpha) and sirtuin 1 (SIRT1) were found in both Reg-P14 and Reg-LI

179 Sirtuin 1 (Sirt1), a class III histone/protein deacetyla

180 We investigated how Sirtuin 1 (SIRT1), a conserved mammalian NAD(+)-dependen

181 Sirtuin 1 (SIRT1), a deacetylase that exerts prosurvival

182 ed activation of KRAS and over-expression of Sirtuin 1 (SIRT1), a histone deacetylase and gene silenc

183 Suppression of deacetylase survival factor sirtuin 1 (SIRT1), a key host defense, is a central feat

184 The NAD(+)-dependent protein deacetylase sirtuin 1 (SIRT1), a key regulator of mammalian metaboli

185 We now report that overexpression of sirtuin 1 (Sirt1), a mediator of the beneficial metaboli

186 e their known interaction in transactivating Sirtuin 1 (SIRT1), a NAD(+)-dependent histone deacetylas

187 the JCI includes studies demonstrating that sirtuin 1 (Sirt1), a NAD+-dependent deacetylase, slows r

188 Anti-aging sirtuin 1 (SIRT1), a NAD+-dependent protein/histone deac

189 We demonstrate that Sirtuin 1 (Sirt1), a redox-sensing deacetylase, selectiv

190 In this study, we report that sirtuin 1 (Sirt1), a type III histone deacetylase, negat

191 Sirtuin 1 (SIRT1), an NAD(+) (nicotinamide adenine dinuc

192 evidence demonstrates the beneficial role of Sirtuin 1 (SIRT1), an NAD(+) dependant deacetylase, in i

193 Sirtuin 1 (SIRT1), an NAD(+)-dependent deacetylase, has

194 Sirtuin 1 (SIRT1), an NAD(+)-dependent deacetylase, is a

195 Sirtuin 1 (SIRT1), an NAD(+)-dependent protein deacetyla

196 Sirtuin 1 (SIRT1), an NAD-dependent deacetylase, partici

197 A "longevity " gene, sirtuin 1 (SIRT1), can attenuate age-dependent induction

198 leotide (NAD+)-dependent deacetylase enzyme, Sirtuin 1 (SIRT1), can prevent activation of these pathw

199 ylation of histone deacetylase 2 (HDAC2) and Sirtuin 1 (SIRT1), deacetylases that participate, respec

200 wattage or nicotine presence, had decreased sirtuin 1 (SIRT1), elevated NADPH oxidase 1, and exhibit

201 y several energy sensing pathways, including sirtuin 1 (SIRT1), forkhead box O (FoxO), AMP-activated

202 Recently, the mammalian ortholog of Sir2, sirtuin 1 (Sirt1), has been identified as a potential tr

203 The protein deacetylase, sirtuin 1 (SIRT1), is a proposed master regulator of exe

204 se p300 and the nutrient-sensing deacetylase sirtuin 1 (SIRT1), maintains energy balance in mice thro

205 itis (EAE) with resveratrol, an activator of sirtuin 1 (SIRT1), reduces disease severity.

206 n of AMP-activated protein kinase (AMPK) and sirtuin 1 (SIRT1), resulting in enhanced mitochondrial o

207 iovascular risk factors on the expression of sirtuin 1 (SIRT1), SIPS, and apoptosis, and we documente

208 cers of fatty acid beta-oxidation, including sirtuin 1 (SIRT1), sirtuin 3 (SIRT3), and Nrf-1.

209 t from activation of the lysine deacetylase, sirtuin 1 (SIRT1), the cAMP pathway, or AMP-activated pr

210 Sirtuin 1 (SIRT1), the founding member of Class III hist

211 how that HAS2 expression can be modulated by sirtuin 1 (SIRT1), the master metabolic sensor of the ce

212 Sirtuin 1 (SIRT1), the most conserved mammalian oxidized

213 inhibitors and RA reduced HDAC1, HDAC4, and sirtuin 1 (SIRT1), which were involved in chromatin remo

214 lation of memory-associated genes, including Sirtuin 1 (Sirt1), within the hippocampus, and thus offe

215 depends on NAD(+) activation of deacetylase sirtuin 1 (SirT1).

216 eraction with the metabolic sensing protein, Sirtuin 1 (SIRT1).

217 tion reaction is reversed by the deacetylase sirtuin 1 (SIRT1).

218 rcetin-3-D-galactoside with -6.9 kcal/mol in sirtuin 1 (Sirt1).

219 tochondrial complex IV subunit I (Mtco1) and sirtuin 1 (Sirt1).

220 on in progerin expression and an increase in sirtuin 1 (SIRT1).

221 interferon alpha (IFN-a), and a mutation in SIRTUIN 1 (SIRT1).

222 gulation of the NAD(+)-dependent deacetylase sirtuin 1 (SIRT1).

223 dinucleotide (NAD(+))-dependent deacetylase Sirtuin 1 (Sirt1).

224 ical and genetic approaches to show that the sirtuin 1 (SIRT1)/FoxO1 signaling pathway in the hypotha

225 oxidase 2 (NOX2); and the down-regulation of Sirtuin 1 (Sirt1)/Timp3 pathways mediate fibrogenic acti

226 chloroethylamide inhibited the expression of Sirtuin-1 (Sirt1) and Rictor, a component of mechanistic

227 Using this continuous assay with sirtuin-1 (Sirt1) and the ADP-ribosyl cyclase CD38, the

228 We focused on sirtuin-1 (SIRT1) deacetylase due to its involvement in

229 miR-34a), thereby reducing the expression of Sirtuin-1 (SIRT1) deacetylase.

230 oxisome proliferator-activated receptor- and sirtuin-1 (SIRT1) expression, with consequent increased

231 The NAD(+)-dependent protein deacetylase Sirtuin-1 (Sirt1) has been implicated in carcinogenesis

232 NAD-dependent deacetylase sirtuin-1 (SIRT1) is a class III histone deacetylase tha

233 Sirtuin-1 (SIRT1) is an NAD-dependent deacetylase posses

234 Sirtuin-1 (SIRT1) is involved in various metabolic pathw

235 opoietin gene transcription due to increased sirtuin-1 (SIRT1) signaling.

236 ducer, its role in OLT and interactions with sirtuin-1 (SIRT1), a key autophagy regulator, have not b

237 Sirtuin-1 (SirT1), a member of the NAD(+)-dependent clas

238 ion by adropin may be mediated by inhibiting Sirtuin-1 (SIRT1), a PGC-1alpha deacetylase.

239 s activate low-energy sensors, which include sirtuin-1 (SIRT1), AMP-activated protein kinase (AMPK),

240 in states of nutrient and oxygen deprivation-sirtuin-1 (SIRT1), AMP-activated protein kinase (AMPK),

241 certain HDACs, especially HDAC6, HDAC9, and Sirtuin-1 (Sirt1), can augment Treg suppressive potency

242 Sirtuin-1 (SIRT1), NAD(+)-dependent deacetylase, has bee

243 otein-cytochrome-C-oxidase subunit-2 (COX2), sirtuin-1 (SIRT1), peroxisome-proliferator-activated-rec

244 ue in response to lipolytic stimulation in a sirtuin-1 (SIRT1)-dependent manner via a mechanism that

245 pendent class III histone deactelyase (HDAC) sirtuin-1 (SIRT1).

246 ation of cytoprotective heme oxygenase-1 and sirtuin-1 (SIRT1).

247 and SIRT1 and the deacetylation of FOXO1 by Sirtuin-1 (SIRT1).

248 ophosphate-activated protein kinase), SIRT1 (sirtuin 1), SIRT3 (sirtuin 3), SIRT6 (sirtuin 6), and PG

249 Transfection of Sirtuin-1 small interfering RNA prevented hnRNP F stimul

250 neurons, an effect that was reversed by the sirtuin 1-specific inhibitor sirtinol.

251 p300, and it is known that Class I HDACs and Sirtuins 1 to 3 can remove histone Kla.

252 hnRNP F stimulated Sirtuin-1 transcription via hnRNP F-responsive element i

253 However, sirtuin 1 was downregulated and so the accumulation of N

254 arget biomolecule, NAD-dependent deacetylase Sirtuin 1, were identified by a contest-based approach,

255 in liver PAFR was associated with increased sirtuin 1 while relocalized PAFR expression was limited

256 We hypothesized that stimulating Sirtuin 1 would increase mitochondrial biogenesis thereb